Combination therapy for neuropathic pain: A review of current evidence

CNS Drugs

Volumn 25, Issue 12, 2011, Pages 1023-1034

  Vorobeychik, Yakov ^a   Gordin, Vitaly ^a   Mao, Jianren ^b   Chen, Lucy ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antidepressants; Antiepileptic drugs; Cancer pain; Capsaicin; Cyclo oxygenase 2 inhibitors; Diabetic neuropathies; Gabapentin; Lidocaine; Neuropathic pain; Opioid analgesics; Postherpetic neuralgia; Pregabalin.

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BACLOFEN; BENZATROPINE; CALCITONIN; CAPSAICIN; CELECOXIB; CLONIDINE; CYCLOOXYGENASE 2 INHIBITOR; DOXEPIN; FLUPIRTINE; GABAPENTIN; GLYCERYL TRINITRATE; IMIPRAMINE; KETAMINE; LAMOTRIGINE; LIDOCAINE; MEMANTINE; MORPHINE; NORTRIPTYLINE; OPIATE; OXYCODONE; PREGABALIN; VALPROIC ACID; VENLAFAXINE;

ADD ON THERAPY; AGNOSIA; CANCER PAIN; COMPLEX REGIONAL PAIN SYNDROME; CONFUSION; COPING BEHAVIOR; DIABETIC NEUROPATHY; DROWSINESS; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG WITHDRAWAL; FEEDBACK SYSTEM; HUMAN; LOW BACK PAIN; LOW DRUG DOSE; MONOTHERAPY; MULTIPLE SCLEROSIS; NERVE INJURY; NEUROPATHIC PAIN; NEUROPATHY; PALLIATIVE THERAPY; PHYSIOTHERAPY; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PSYCHOTHERAPY; RADICULOPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL CORD INJURY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIGEMINUS NEURALGIA; UNSPECIFIED SIDE EFFECT; VERTEBRAL CANAL STENOSIS; XEROSTOMIA;

ANALGESICS; ANESTHETICS, COMBINED; ANTIDEPRESSIVE AGENTS; DRUG THERAPY, COMBINATION; HUMANS; NEURALGIA;

EID: 82555177320     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11596280-000000000-00000     Document Type: Review

References (77)

1. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical research purposes. Neurology 2008; 70 (18): 1630-5 (Pubitemid 351620320)
2. Willis Jr WD. Central nervous system mechanisms for pain modulation. Appl Neurophysiol 1985; 48 (1-6): 153-65 (Pubitemid 16064587)
3. Dubner R, Hargreaves KM. The neurobiology of pain and its modulation. Clin J Pain 1989; 5 Suppl. 2: S1-4
4. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288 (5472): 1765-9
5. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001; 413 (6852): 203-10 (Pubitemid 32867885)
6. Woolf CJ, King AE. Dynamic alterations in the cutaneous mechanoreceptive fields of dorsal horn neurons in the rat spinal cord. J Neurosci 1990; 10: 2717-26
7. Ren K, Hylden JL, Williams GM, et al. The effects of a noncompetitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain 1992; 50 Suppl. 3: 331-44
8. Willis Jr WD. Role of neurotransmitters in sensitization of pain responses. Ann NY Acad Sci 2001; 933: 142-56 9. Mendell LM, Wall PD. Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 1965; 206: 97-9
9. Price DD, Hayes RL, Ruda M, et al. Neural representation of cutaneous aftersensations by spinothalamic tract neurons. Fed Proc 1978; 37 Suppl. 9: 2237-9 (Pubitemid 8373651)
10. Kenshalo Jr DR, Leonard RB, Chung JM, et al. Responses of primate spinothalamic neurons to graded and to repeated noxious heat stimuli. J Neurophysiol 1979; 42: 1370-89 (Pubitemid 10229771)
11. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983; 306 Suppl. 5944: 686-8 (Pubitemid 14201852)
12. Mao J, Mayer DJ, Hayes RL, et al. Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in 14C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy. J Neurophysiol 1993; 70: 470-81 (Pubitemid 23239180)
13. Mao J, Mayer DJ, Price DD. Patterns of increased brain activity indicative of pain in a rat model of peripheral mononeuropathy. J Neurosci 1993; 13: 2689-702 (Pubitemid 23151783)
14. Zhuo M. Glutamate receptors and persistent pain: targeting forebrain NR2B subunits. Drug Discov Today 2002; 7: 259-67 (Pubitemid 34144617)
15. Simone DA, Zhang X, Li J, et al. Comparison of responses of primate spinothalamic tract neurons to pruritic and al-gogenic stimuli. J Neurophysiol 2004; 91: 213-22 (Pubitemid 38084366)
16. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984; 7: 309-38 (Pubitemid 14155301)
17. Porreca F, Lai J, Bian D, et al. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc Natl Acad Sci USA 1999; 96 Suppl. 14: 7640-4 (Pubitemid 29328333)
18. Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev 2004; 27: 729-37 (Pubitemid 38199605)
19. Sorkin LS, Westlund KN, Sluka KA, et al. Neural changes in acute arthritis in monkeys: IV. Time-course of amino acid release into the lumbar dorsal horn. Brain Res Brain Res Rev 1992; 17: 39-50
20. Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 2002; 25: 319-25 (Pubitemid 34667014)
21. Waxman SG, Dib-Hajj S, Cummins TR, et al. Sodium channels and pain. Proc Natl Acad Sci USA 1999; 96: 7635-9 (Pubitemid 29328332)
22. Watkins LR, Maier SF. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2003; 2 Suppl. 12: 973-85 (Pubitemid 37540579)
23. Sung B, Lim G, Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 2003; 23: 2899-910 (Pubitemid 36418626)
24. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2007; (4): CD005454
25. Malanga G, Reiter RD, Garay E. Update on tizanidine for muscle spasticity and emerging indications. Expert Opin Pharmacother 2008; 9 Suppl. 12: 2209-15
26. Sinatra R. The fentanyl HCl patient-controlled transdermal system (PCTS): an alternative to intravenous patient-controlled analgesia in the postoperative setting. Clin Pharmacokinet 2005; 44 Suppl. 1: 1-6 (Pubitemid 41626711)
27. Sittl R. Transdermal buprenorphine in the treatment of chronic pain. Expert Rev Neurother 2005; 5 Suppl. 3: 315-23 (Pubitemid 40705273)
28. Kaplan KM, Brose WG. Intrathecal methods. Neurosurg Clin N Am 2004; 15 Suppl. 3: 289-96 (Pubitemid 38891623)
29. Simpson Jr RK. Mechanisms of action of intrathecal medications. Neurosurg Clin N Am 2003; 14 Suppl. 3: 353-64
30. Bennett G, Deer T, Du Pen S, et al. Future directions in the management of pain by intraspinal drug delivery. J Pain Symptom Manage 2000; 20 Suppl. 2: S44-50
31. Yaksh TL. Spinal pharmacology of pain and its modulation. Clin Neurosurg 1983; 31: 291-303
32. Yaksh TL. New horizons in our understanding of the spinal physiology and pharmacology of pain processing. Semin Oncol 1993; 20 (2 Suppl. 1): 6-18 (Pubitemid 23111516)
33. Yaksh TL. Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci 1999; 20 Suppl. 8: 329-37 (Pubitemid 29366811)
34. Coluzzi PH. Sublingual morphine: efficacy reviewed. J Pain Symptom Manage 1998; 16 Suppl. 3: 184-92 (Pubitemid 28429067)
35. Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85 (3 Suppl.): S3-14
36. Mao J, Gold MS, Backonja MM. Combination drug therapy for chronic pain: a call for more clinical studies. J Pain 2011; 12 (2): 157-66
37. Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother 2005; 5: 823-30 (Pubitemid 41679649)
38. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011; 152 (3 Suppl.): S2-15
39. Gilron I, Bailey JM, Tu D, et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009; 374: 1252-61
40. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 2001; 3 (2): 53-62 (Pubitemid 33130299)
41. Hanna M, O'Brien C, Wilson MC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008; 12 (6): 804-13
42. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352 (13): 1324-34 (Pubitemid 40411499)
43. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837-42 (Pubitemid 28544424)
44. Gatti A, Sabato AF, Occhioni R, et al. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study. Eur Neurol 2009; 61 (3): 129-37
45. Romano CL, Romano D, Bonora C, et al. Pregabalin, celecoxib, celecoxib, and their combination for treatment of chronic low back pain. J Orthop Traumatol 2009; 10 (4): 185-91
46. Dworkin RH, Corbin AE, Young Jr JP, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003; 60: 1274-83 (Pubitemid 36460982)
47. Sabatowski R, Galvez R, Cherry DA, et al., 1008-045 Study Group. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled clinical trial. Pain 2004; 109 (1-2): 26-35 (Pubitemid 38479767)
48. Zin CS, Nissen LM, O'Callaghan JP, et al. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. J Pain 2010; 11 (5): 462-71
49. Baron R, Mayoral V, Leijon G, et al. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 2009; 25 (7): 1677-87
50. Backonja M, Wallace MS, Blonsky ER, et al., NGX-4010 C116 Study Group. NGX-4010, a high-concentration capsai-cin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 2008; 7: 1106-12
51. Simpson DM, Brown S, Tobias J. Controlled trial of highconcentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008; 70 (24): 2305-13
52. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000; 49: 574-9 (Pubitemid 30326557)
53. Gustin SM, Schwarz A, Birbaumer N, et al. NMDAreceptor antagonist and morphine decrease CRPS-pain and cerebral pain representation. Pain 2010; 151 (1): 69-76
54. Siddall PJ, Molloy AR, Walker S, et al. The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury. Anesth Analg 2000; 91: 1493-8
55. Agrawal RP, Goswami J, Jain S, et al. Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study. Diabetes Res Clin Pract 2009; 83 (3): 371-8
56. Khoromi S, Cui L, Nackers L, et al. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain 2007; 130 (1-2): 66-75 (Pubitemid 46850784)
57. Silver M, Blum D, Grainger J, et al. Double-blind, placebocontrolled trial of lamotrigine in combination with other medications for neuropathic pain. J Pain Symptom Manage 2007; 34 (4): 446-54 (Pubitemid 47446144)
58. Eichenberger U, Neff F, Sveticic G, et al. Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth Analg 2008; 106: 1265-73 (Pubitemid 351450557)
59. Lynch ME, Clark AJ, Sawynok J, et al. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. An-esthesiology 2005; 103: 140-6 (Pubitemid 40943146)
60. Baron R. Neuropathic pain: a clinical perspective. Handb Exp Pharmacol 2009; (194): 3-30
61. Zin CS, Nissen LM, Smith MT, et al. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs 2008; 22 (5): 417-42
62. World Health Organization. Cancer pain relief with a guide to opioid availability. 2nd ed. Geneva: World Health Organization, 1996
63. Lussier D, Portenoy RK. Adjuvant analgesics in pain management. In: Doyle D, Hanks G, Cherny NI, et al. Oxford textbook of palliative medicine. 3rd ed. New York (NY): Oxford University Press, 2003: 349-78
64. Zech DFJ, Grond S, Lynch J, et al. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 1995; 63: 65-76
65. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999; 81: 129-34 (Pubitemid 29199908)
66. Twycross R, Wilcock A. Symptom management in advanced cancer. 3rd ed. Abingdon: Radcliffe Medical Press, 2001
67. Wall PD, Melzack R. Textbook of pain. 5th ed. Philadelphia (PA): Churchill Livingstone, 2005
68. Mercadante S, Arcuri E, Tirelli W, et al. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori 2002; 88 (3): 239-42 (Pubitemid 34875452)
69. Goodchild CS, Nelson J, Cooke I, et al. Combination therapy with flupirtine and opioid: open-label case series in the treatment of neuropathic pain associated with cancer. Pain Med 2008; 9 (7): 939-49
70. Kannan TR, Saxena A, Bhatnagar S, et al. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J Pain Symptom Manage 2002 Jan; 23 (1): 60-5 (Pubitemid 34093884)
71. Yomiya K, Matsuo N, Tomiyasu S, et al. Baclofen as an adjuvant analgesic for cancer pain. Am J Hosp Palliat Care 2009; 26 (2): 112-8
72. Keskinbora K, Pekel AF, Aydinli I. Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial. J Pain Symptom Manage 2007 Aug; 34 (2): 183-9 (Pubitemid 47088905)
73. Takahashi H, Shimoyama N. A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain. Int J Clin Oncol 2010 Feb; 15 (1): 46-51
74. Arai YC, Matsubara T, Shimo K, et al. Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine. J Anesth 2010 Jun; 24 (3): 407-10
75. Kornhuber J, Bleich S, Wiltfang J, et al. Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. J Neural Transm 1999; 106 (9-10): 857-67 (Pubitemid 29516055)
76. Virani A, Mailis A, Shapiro LE, et al. Drug interactions in human neuropathic pain pharmacotherapy. Pain 1997; 73 (1): 3-13 (Pubitemid 27470820)
77. Haanpaa ML, Gourlay GK, Kent JL, et al. Treatment considerations for patients with neuropathic pain and other medical comorbidities. Mayo Clin Proc 2010; 85 (3 Suppl.): S15-25